AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Canopy Growth Corp (NASDAQ:CGC)
1.19 USD
+0.010 0.848%Sponsored Reports
Loading...
| Previous Close (in USD) | 1.18 |
|---|---|
| Change | +0.010 0.848% |
| 52 W H/L (in USD) | 19.200/2.755 |
| EBITDA (in USD) | -245.696M |
| PE Ratio | -- |
| Volume | 12290660 |
| Diluted Eps TTM | -14.34 |
| Total Assets (in USD) | 2439.098M |
|---|---|
| Total Liabilities (in USD) | 1679.076M |
| Revenue TTM (in USD) | 362.244M |
| Cash (in USD) | 677.007M |
| Market Cap (in USD) | 637.476 M |
| Revenue Per Share TTM | 5.589 |
| Gross Profit TTM (in USD) | -81.938M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Canopy Growth Corp
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Employees: 1621
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. David Eric Klein | CEO & Director | 1964 |
| 2. | Ms. Judy Eunjoo Hong | VP of Investor Relations & Competitive Intelligence, Chief of Staff to the CEO and CFO | 1973 |
| 3. | Mr. Julious C. Grant Jr. | Chief Commercial Officer | 1968 |
| 4. | Mr. Jonathan Di Tosto | Chief Operations Officer | NA |
| 5. | Mr. Thomas Carlton Stewart | VP & Chief Accounting Officer | 1982 |
| 6. | Mr. Thomas Shipley IV | Sr. VP of Quality Assurance & Chief Science Officer | 1989 |
| 7. | Dr. Christelle Gedeon L.L.B., Ph.D. | Chief Legal Officer | 1982 |
| 8. | Mr. Timothy Rob Saunders F.C.A., FCPA | Strategic Advisor | 1961 |
| 9. | Jason Green | Head of Agriculture - Hemp Division | NA |
| 10. | Dr. Mark A. Ware | Chief Medical Officer | NA |
Peers
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ZTS
Zoetis Inc |
+1.910 1.301% | 147.23 | 40.180 | 30.960 | 10.675 | 17.597 | 11.271 | 26.180 |
|
MKKGY
Merck KGaA ADR |
-0.270 1.008% | 26.11 | 21.250 | 14.925 | 3.099 | 2.143 | 3.605 | 12.978 |
|
MKGAF
MERCK Kommanditgesellschaft auf Aktien |
-5.720 4.208% | 130.21 | 21.730 | 14.948 | 3.159 | 2.147 | 3.562 | 12.822 |
|
TAK
Takeda Pharmaceutical Co Ltd ADR |
+0.060 0.410% | 14.56 | 32.670 | 11.534 | 0.011 | 0.874 | 0.018 | 0.069 |
Income Statement
(Currency in USD)| Breakdown | 31-03-2023 | 31-03-2022 | 31-03-2021 | 31-03-2020 | 31-03-2019 |
|---|---|---|---|---|---|
| Income Before Tax | -3314.32M | -329.433M | -1683.961M | -1509.054M | -657.776M |
| Minority Interest | 31.388M | 18.304M | 140.009M | 291.508M | 291.885M |
| Net Income | -3309.546M | -320.485M | -1670.82M | -1387.44M | -670.094M |
| Selling General Administrative | 487.413M | 520.281M | 666.538M | 624.911M | 451.435M |
| Gross Profit | -104.14M | -193.054M | 66.96M | -31.684M | 88.93M |
| Reconciled Depreciation | 84.517M | 114.418M | 127.118M | 125.013M | 46.918M |
| Ebit | 1665.189M | -1082.674M | 44.3M | -1668.963M | -553.645M |
| Ebitda | 1749.706M | -229.578M | 171.418M | -1357.226M | -483.333M |
| Depreciation And Amortization | 84.517M | 853.096M | 127.118M | 311.737M | 70.312M |
| Operating Income | 1665.189M | -1082.674M | 44.3M | -1668.963M | -553.645M |
| Other Operating Expenses | 994.457M | 1233.66M | 1146.227M | 1423.629M | 779.986M |
| Interest Expense | 126.16M | 103.944M | 8.459M | 6.716M | 18.415M |
| Tax Provision | -4.774M | -8.948M | -13.141M | -121.614M | 4.112M |
| Interest Income | 24.282M | 6.601M | 21.367M | 84.68M | 88.749M |
| Net Interest Income | -101.878M | -97.343M | 12.908M | 59.611M | 30.897M |
| Income Tax Expense | -4.774M | -8.948M | -13.141M | -121.614M | 12.318M |
| Total Revenue | 402.904M | 520.325M | 546.649M | 398.772M | 226.341M |
| Total Operating Expenses | 487.413M | 520.281M | 666.538M | 993.173M | 642.575M |
| Cost Of Revenue | 507.044M | 713.379M | 479.689M | 430.456M | 137.411M |
| Total Other Income Expense Net | -4979.509M | 753.241M | -1728.261M | 159.909M | -104.131M |
| Net Income From Continuing Ops | -3309.546M | -320.485M | -1670.82M | -1387.44M | -670.094M |
| Net Income Applicable To Common Shares | - | -302.181M | -1744.92M | -1321.326M | -736.281M |
Balance Sheet
(Currency in USD)| Breakdown | 31-03-2023 | 31-03-2022 | 31-03-2021 | 31-03-2020 | 31-03-2019 |
|---|---|---|---|---|---|
| Total Assets | 2439.098M | 5615.05M | 6823.48M | 6857.745M | 8731.805M |
| Intangible Assets | 188.719M | 252.695M | 308.167M | 476.366M | 519.556M |
| Other Current Assets | 10.115M | 19.065M | 67.232M | 14.681M | 78.975M |
| Total Liab | 1679.076M | 1984.553M | 3201.66M | 1679.875M | 1490.357M |
| Total Stockholder Equity | 758.435M | 3589.956M | 3481.811M | 4886.362M | 6951.633M |
| Other Current Liab | 94.727M | 139.332M | 106.428M | 199.355M | 81.414M |
| Common Stock | 7938.571M | 7482.809M | 7168.557M | 6373.544M | 6026.618M |
| Capital Stock | 7938.571M | 7482.809M | 7168.557M | 6373.544M | 6026.618M |
| Retained Earnings | -9672.761M | -6370.337M | -6068.156M | -4323.236M | -777.087M |
| Good Will | 85.563M | 1866.503M | 1889.354M | 1954.471M | 1544.055M |
| Other Assets | - | 15.342M | 4.961M | 22.636M | 25.902M |
| Cash | 677.007M | 776.005M | 1154.653M | 1303.176M | 2480.83M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 803.842M | 212.898M | 284.33M | 420.589M | 411.663M |
| Current Deferred Revenue | 75.991M | - | 100.813M | 41.092M | 37.613M |
| Net Debt | 629.874M | 724.986M | 428.31M | -677.358M | -1534.855M |
| Short Term Debt | 556.89M | 9.296M | 9.827M | 56.749M | 103.716M |
| Short Long Term Debt | 556.89M | 9.296M | 9.827M | 16.393M | 103.716M |
| Short Long Term Debt Total | 1306.881M | 1500.991M | 1582.963M | 625.818M | 945.975M |
| Other Stockholder Equity | -7166.276M | 2519.766M | 2415.65M | 2615.155M | 2037.25M |
| Property Plant Equipment | - | 942.78M | 1074.537M | 1524.803M | 1096.34M |
| Total Current Assets | 1077.254M | 1737.402M | 2838.194M | 2564.373M | 5070.14M |
| Long Term Investments | 568.292M | 341.733M | 708.267M | 315.096M | 475.812M |
| Short Term Investments | 105.595M | 595.651M | 1144.563M | 673.323M | 2034.133M |
| Net Receivables | 93.987M | 96.443M | 92.435M | 90.155M | 106.974M |
| Long Term Debt | 749.991M | 1491.695M | 1573.136M | 449.022M | 842.259M |
| Inventory | 148.901M | 204.387M | 367.979M | 391.086M | 262.105M |
| Accounts Payable | 76.234M | 64.27M | 67.262M | 123.393M | 188.92M |
| Accumulated Other Comprehensive Income | -13.86M | -42.282M | -34.24M | 220.899M | 1702.102M |
| Non Currrent Assets Other | 19.447M | -0.649M | -16.418M | -24.477M | 25.902M |
| Non Current Assets Total | 1361.844M | 3877.648M | 3985.286M | 4293.372M | 3661.665M |
| Capital Lease Obligations | 109.309M | 139.16M | 136.225M | 40.356M | 0M |
| Long Term Debt Total | - | - | - | 500.66M | 842.259M |
Cash Flow
(Currency in USD)| Breakdown | 31-03-2023 | 31-03-2022 | 31-03-2021 | 31-03-2020 | 31-03-2019 |
|---|---|---|---|---|---|
| Investments | 433.379M | 166.577M | -497.555M | 1292.757M | -2158.045M |
| Total Cashflows From Investing Activities | - | 230.819M | -884.105M | -347.654M | -3227.985M |
| Total Cash From Financing Activities | -19.694M | -45.533M | 1264.769M | -57.161M | 5837.198M |
| Net Income | -3309.546M | -320.485M | -1670.82M | -1387.44M | -670.094M |
| Change In Cash | -98.998M | -378.648M | -148.523M | -1177.654M | 2158.27M |
| Begin Period Cash Flow | 776.005M | 1154.653M | 1303.176M | 2480.83M | 322.56M |
| End Period Cash Flow | 677.007M | 776.005M | 1154.653M | 1303.176M | 2480.83M |
| Total Cash From Operating Activities | -557.546M | -545.811M | -465.729M | -772.635M | -520.51M |
| Depreciation | 84.517M | 114.418M | 127.118M | 125.013M | 46.918M |
| Other Cashflows From Investing Activities | - | -18.126M | -66.746M | -419.672M | -419.672M |
| Dividends Paid | - | - | - | - | 0M |
| Change To Inventory | 55.638M | 173.189M | 17.211M | -177.091M | -144.917M |
| Sale Purchase Of Stock | - | - | - | 43.031M | 5294.425M |
| Other Cashflows From Financing Activities | 97.436M | 2.53M | 1279.008M | 56.62M | 614.402M |
| Capital Expenditures | 10.554M | 48.113M | 174.141M | 721.901M | 682.746M |
| Change In Working Capital | 65.845M | 165.558M | -4.333M | -203.779M | -262.168M |
| Other Non Cash Items | 2575.224M | -543.879M | 1004.298M | 494.909M | 64.734M |
| Free Cash Flow | -568.1M | -593.924M | -639.87M | -1494.536M | -1203.256M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Amplify Alternative Harvest ETF | 11 months ago | 2516529 |
| 2. | Lord Abbett & Co. Convertibles | 1 year ago | 495344 |
| 3. | Lord Abbett Convertible I | 1 year ago | 495344 |
| 4. | Global X Marijuana Life Sciences ETF | 11 months ago | 357340 |
| 5. | Vitreo Canabidiol FIA IE | 1 year ago | 171680 |
| 6. | CANSOUL Fonds Hanf Aktien Global EUR C | 1 year ago | 57000 |
| 7. | AdvisorShares Pure Cannabis ETF | 11 months ago | 46922 |
| 8. | I.B.I TRK Solactive N.Amer Cannabis $Hdg | 1 year ago | 37814 |
| 9. | TD Canadian Equity Index ETF | 11 months ago | 36301 |
| 10. | Amplify Seymour Cannabis ETF | 11 months ago | 36276 |
| 11. | SPDR® S&P International Small Cap ETF | 11 months ago | 31611 |
| 12. | Mackenzie Canadian Equity ETF | 11 months ago | 29063 |
| 13. | TD Canadian Index - I | 1 year ago | 24253 |
| 14. | Fintrust Income and Opportunity Instl | 1 year ago | 21500 |
| 15. | SPDR® Portfolio Developed Wld ex-US ETF | 11 months ago | 14650 |
| 16. | I.B.I TRK Solactive N American Cannabis | 1 year ago | 11557 |
| 17. | Scotia Canadian Equity Index A | 1 year ago | 10006 |
| 18. | Ayalon Global Cannabis | 1 year ago | 5762 |
| 19. | CI Canadian Equity ETF | 11 months ago | 3428 |
| 20. | Stratégie Santé | 1 year ago | 3267 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Lord, Abbett & Co LLC | 1 year ago | 495344 |
| 2. | Susquehanna International Group, LLP | 1 year ago | 339420 |
| 3. | Millennium Management LLC | 1 year ago | 317373 |
| 4. | JANE STREET GROUP, LLC | 1 year ago | 307130 |
| 5. | Mirae Asset Global Investments (Korea) Co Ltd | 1 year ago | 215817 |
| 6. | Morgan Stanley - Brokerage Accounts | 1 year ago | 207785 |
| 7. | SIMPLEX TRADING, LLC | 1 year ago | 117294 |
| 8. | Goldman Sachs Group Inc | 1 year ago | 110790 |
| 9. | D. E. Shaw & Co LP | 1 year ago | 90010 |
| 10. | Renaissance Technologies Corp | 1 year ago | 79308 |
| 11. | OLD MISSION CAPITAL LLC | 1 year ago | 75407 |
| 12. | TD Asset Management Inc | 1 year ago | 64382 |
| 13. | Virtu Financial LLC | 1 year ago | 63080 |
| 14. | Baader Bank INC | 1 year ago | 57000 |
| 15. | Royal Bank of Canada | 1 year ago | 51831 |
| 16. | Commonwealth Equity Services Inc | 1 year ago | 50778 |
| 17. | Scotia Capital Inc | 1 year ago | 49200 |
| 18. | LPL Financial Corp | 1 year ago | 46907 |
| 19. | Group One Trading, LP | 1 year ago | 46072 |
| 20. | AdvisorShares Investments, LLC | 1 year ago | 36923 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Related Articles
Loading...
